Effects of Antipsychotic Medication on Mortality in Long-Term Care Home Residents
| Autor: | Peter Brink, Michael J. Stones, Jason Randle |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
business.industry Care homes medicine.medical_treatment High mortality InformationSystems_INFORMATIONSTORAGEANDRETRIEVAL medicine.disease 03 medical and health sciences Long-term care 0302 clinical medicine Mortality data Pro re nata Emergency medicine Data_FILES Medicine Dementia 030212 general & internal medicine business Antipsychotic GeneralLiterature_REFERENCE(e.g. dictionaries encyclopedias glossaries) 030217 neurology & neurosurgery |
| Popis: | This chapter examines mortality in long-term care home (LTCH) residents as associated with the use antipsychotic medication when combined with other psychotropic medications. The data at census-level pertain to all new admissions to long-term care homes (LTCH) in Ontario, Canada, during a given financial year (i.e., over 20,000 LTCH residents). The observations include comprehensive assessment upon admission and at quarterly intervals thereafter for a maximal period of 1-year after the initial assessment. The mortality data derive from three linked databases, with mortality classified as death within 90 days of the final assessment. The findings indicate that combinations of concurrent daily usage of antipsychotic medication with daily usage of other psychotropic medications (particularly antidepressants and analgesics) are associated with relatively low mortality, whereas intermittent usage (e.g. pro re nata; as needed) is associated with relatively high mortality. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|